Want to join the conversation?
$PBCT 2Q15 Call – John, CEO: As expected operating expenses improved from the 1Q15 primarily resulting from lower compensation and benefits cost. On YoverY basis, operating expenses were slightly higher; however, we remain confident in our ability to control cost and ongoing impact of strategic investments & increasing regulatory compliance costs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?